New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ARP;ZTS;OII;NCS;NILE;SSH;PTEN;NOV;HP;SFLY;OIS;NBR;EW;SPN;PDS From The Last 14 Days
Check below for free stories on ARP;ZTS;OII;NCS;NILE;SSH;PTEN;NOV;HP;SFLY;OIS;NBR;EW;SPN;PDS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 16, 2014
07:36 EDTNCSCredit Suisse to hold a conference
Subscribe for More Information
07:27 EDTEWEdwards Lifesciences price target raised to $114 from $103 at Canaccord
Canaccord raised its price target on Edwards Lifesciences to $114 from $103 following positive updates on the SAPIEM franchise and on the heels of several positive trends and upside surprises across the businesses during the quarter. Canaccord maintains its Buy rating on the stock.
06:09 EDTSSHSunshine Heart to present data from six patients implanted with C-Pulse system
Sunshine Heart announced that follow-up data from six patients implanted with the C-Pulse Heart Assist System at St. Luke's Hospital Mid America Heart Institute, as part of a FDA approved, North American Feasibility Study, will be presented later today by Dr. Sanjeev Aggarwal, Director of Mechanical Circulatory Support at Saint Luke's Mid America Heart Institute. Prior to his clinical presentation at the TCT Conference, Dr. Aggarwal will present on a few of these patients who demonstrated clinical signs of myocardial recovery to the investment community at Sunshine Heart's fourth annual analyst and investor breakfast that begins at 7:00am today at the Grand Hyatt Washington.
September 15, 2014
07:45 EDTEW, SSHCardiovascular Research Foundation to hold a conference
Transcatheter Cardiovascular Therapeutics: TCT 2014 to be held in Washington, D.C. on September 13-17 with some presentations being webcasted. Webcast Link
September 14, 2014
13:18 EDTEWEdwards Lifesciences presents five-year clinical outcomes of PARTNER trial
Edwards Lifesciences announced the presentation of five-year clinical outcomes for inoperable patients treated in The PARTNER Trial, the world's only prospective randomized trial for transcatheter aortic valve replacement, TAVR, in patients deemed too sick for open-heart surgery. The data were presented as part of the late-breaking clinical trials session at the 26th Transcatheter Cardiovascular Therapeutics, TCT, the annual scientific symposium of the Cardiovascular Research Foundation."These longer term results from PARTNER's inoperable cohort indicated that TAVR was associated with a continued significant mortality benefit, persistent symptom benefit and a statistically significant reduction in rehospitalizations," said Michael J. Mack, M.D., chair, cardiovascular service line, Baylor Scott & White Health. "It is reassuring now five years later that in this very ill and elderly patient group facing a high likelihood of mortality, more patients treated with SAPIEN experienced sustained improvements in functional heart status and fewer repeat hospitalizations two measures that signify an improvement in quality of life." "This was the first study of its kind for transcatheter heart valves," said Mack. "The PARTNER Trial has historical significance in the development of TAVR and continues to provide the clinical community with important information about the durability and performance of the Edwards SAPIEN valves."
September 12, 2014
15:29 EDTSFLYHP exploring sale of Snapfish photo service, Reuters reports
Subscribe for More Information
15:26 EDTSFLYHP exploring sale of Snapfish photo service, Reuters reports
Subscribe for More Information
15:03 EDTEWSt. Jude Medical pausing Portico sales, implants, says Wells Fargo
Subscribe for More Information
September 11, 2014
15:33 EDTNBRNabors to repurchase about $250M of shares, about 40% of Pamplona stake
Subscribe for More Information
12:17 EDTSSHSunshine Heart to hold an analyst and investor breakfast meeting
Subscribe for More Information
10:00 EDTEWOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Airgas (ARG) initiated with a Neutral at Northcoast... CBOE Holdings (CBOE) initiated with a Buy at Deutsche Bank... CME Group (CME) initiated with a Buy at Deutsche Bank... Colfax (CFX) initiated with a Neutral at Northcoast... Corporate Office Properties (OFC) initiated with an Overweight at Capital One... Edwards Lifesciences (EW) initiated with a Buy at Sterne Agee... Energen (EGN) initiated with a Buy at Deutsche Bank... Goodrich Petroleum (GDP) initiated with an Outperform at Cowen... GreenHunter Resources (GRH) initiated with a Hold at Stifel... GrubHub (GRUB) initiated with a Market Perform at Barrington... Illinois Tool Works (ITW) initiated with a Neutral at Northcoast... IntercontinentalExchange (ICE) initiated with a Hold at Deutsche Bank... JD.com (JD) initiated with a Buy at Brean Capital... Lincoln Electric (LECO) initiated with a Buy at Northcoast... Live Nation (LYV) initiated with a Buy at Jefferies... Medtronic (MDT) initiated with a Neutral at Sterne Agee... Midstates Petroleum (MPO) initiated with a Market Perform at Cowen... NASDAQ (NDAQ) initiated with a Hold at Deutsche Bank... Newfield Exploration (NFX) initiated with an Outperform at Iberia... Newpark Resources (NR) initiated with an Outperform at Credit Suisse... Nuverra Environmental (NES) initiated with a Buy at Stifel... Palo Alto (PANW) initiated with a Buy at Roth Capital... Petrobras (PBR) initiated with an Outperform at Cowen... RSP Permian (RSPP) initiated with a Hold at Deutsche Bank... Sensata (ST) initiated with an Equal Weight at Morgan Stanley... Stage Stores (SSI) initiated with a Neutral at Credit Suisse... Synergy Resources (SYRG) initiated with an Outperform at Cowen... TE Connectivity (TEL) initiated with an Overweight at Morgan Stanley... Twitter (TWTR) initiated with a Buy at Canaccord... Walter Investment (WAC) initiated with an Underweight at Barclays... Washington REIT (WRE) initiated with an Equalweight at Capital One... Yandex (YNDX) initiated with a Buy at Canaccord... Yara International (YARIY) initiated with a Neutral at Credit Suisse.
10:00 EDTHPOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:08 EDTNBRNabors Industries 25.6M share Spot Secondary priced at $24.10
Subscribe for More Information
07:35 EDTHPHelmerich & Payne upgraded to Buy from Hold at Argus
Subscribe for More Information
05:54 EDTSPNSuperior Energy management to meet with Sterne Agee
Subscribe for More Information
September 10, 2014
17:04 EDTOIIOceaneering's contract with BP Angla extended
Subscribe for More Information
16:09 EDTEWEdwards Lifesciences initiated with a Buy at Sterne Agee
Subscribe for More Information
11:05 EDTZTSZoetis downgraded to Long-Term Buy from Buy at Hilliard Lyons
September 9, 2014
07:18 EDTHP, PTENStephens to hold an investor trip
Energy: Oilfield Services Investor Plane Trip travels throughout Texas and Oklahoma on September 9-10.
07:08 EDTPDSPeters & Co. Ltd to h old a conference
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use